Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus

Christopher Fawsitt; Peter Vickerman; Graham S Cooke; Nicky J Welton

doi:10.1016/j.jval.2018.04.043

Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus

Christopher Fawsitt
, Peter Vickerman
, Graham S Cooke
, Nicky J Welton

Research output: Contribution to journal › Article (Academic Journal) › peer-review

96 Downloads (Pure)

Original language	English
Journal	Value in Health
DOIs	https://doi.org/10.1016/j.jval.2018.04.043
Publication status	Published - 27 Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Groups and Themes

GEM-B

Access to Document

10.1016/j.jval.2018.04.043

Full-text PDF (author’s accepted manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at 10.1016/j.jval.2018.04.043. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 183 KB
Full-text PDF (author’s accepted manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Elsevier at 10.1016/j.jval.2018.04.043. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 316 KB

Handle.net

Persistent link

Professor Nicky J Welton
- Nicky.Weltonbristol.acuk
- Applied Health Research - Professor in Statistical and Health Economic Modelling
- Bristol Population Health Science Institute
- Health Protection Research Unit (HPRU)
- Centre for Academic Primary Care
Person: Academic , Member

Cite this

@article{512e12c7a48f42ecb5ac85011a2c4986,

title = "Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-na{\"i}ve patients with chronic hepatitis c virus",

author = "Christopher Fawsitt and Peter Vickerman and Cooke, \{Graham S\} and Welton, \{Nicky J\}",

year = "2019",

month = aug,

day = "27",

doi = "10.1016/j.jval.2018.04.043",

language = "English",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Limited",

}

Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus. / Fawsitt, Christopher; Vickerman, Peter; Cooke, Graham S et al.
In: Value in Health, 27.08.2019.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus

AU - Fawsitt, Christopher

AU - Vickerman, Peter

AU - Cooke, Graham S

AU - Welton, Nicky J

PY - 2019/8/27

Y1 - 2019/8/27

U2 - 10.1016/j.jval.2018.04.043

DO - 10.1016/j.jval.2018.04.043

M3 - Article (Academic Journal)

SN - 1098-3015

JO - Value in Health

JF - Value in Health

ER -

Cost-effectiveness analysis of baseline testing for resistance-associated polymorphisms to optimise treatment outcome in genotype 1 non-cirrhotic treatment-naïve patients with chronic hepatitis c virus

UN SDGs

Research Groups and Themes

Access to Document

Handle.net

Profiles

Professor Nicky J Welton

Cite this